Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

97 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparing methods for full versus single technology appraisal: a case study of docetaxel and paclitaxel for early breast cancer.
Kaltenthaler E, Tappenden P, Booth A, Akehurst R. Kaltenthaler E, et al. Among authors: akehurst r. Health Policy. 2008 Sep;87(3):389-400. doi: 10.1016/j.healthpol.2008.02.007. Epub 2008 Apr 2. Health Policy. 2008. PMID: 18387689
Adjusting survival time estimates to account for treatment switching in randomized controlled trials--an economic evaluation context: methods, limitations, and recommendations.
Latimer NR, Abrams KR, Lambert PC, Crowther MJ, Wailoo AJ, Morden JP, Akehurst RL, Campbell MJ. Latimer NR, et al. Among authors: akehurst rl. Med Decis Making. 2014 Apr;34(3):387-402. doi: 10.1177/0272989X13520192. Epub 2014 Jan 21. Med Decis Making. 2014. PMID: 24449433
Economic implications of the use of basiliximab in addition to triple immunosuppressive therapy in renal allograft recipients: a UK perspective.
Walters SJ, Whitfield M, Akehurst RL, Chilcott JB. Walters SJ, et al. Pharmacoeconomics. 2003;21(2):129-38. doi: 10.2165/00019053-200321020-00005. Pharmacoeconomics. 2003. PMID: 12515574 Clinical Trial.
New therapeutic products and difficult decisions. The case of recombinant factor VIII in the management of haemophilia A.
Green C, Akehurst R. Green C, et al. Among authors: akehurst r. J Public Health Med. 1998 Jun;20(2):137-8. doi: 10.1093/oxfordjournals.pubmed.a024732. J Public Health Med. 1998. PMID: 9675729
Modelling in health economic evaluation. What is its place? What is its value?
Brennan A, Akehurst R. Brennan A, et al. Among authors: akehurst r. Pharmacoeconomics. 2000 May;17(5):445-59. doi: 10.2165/00019053-200017050-00004. Pharmacoeconomics. 2000. PMID: 10977387 Review.
Treatment of irritable bowel syndrome: a review of randomised controlled trials.
Akehurst R, Kaltenthaler E. Akehurst R, et al. Gut. 2001 Feb;48(2):272-82. doi: 10.1136/gut.48.2.272. Gut. 2001. PMID: 11156653 Free PMC article. Review.
The cost-effectiveness of celecoxib vs diclofenac in the treatment of osteoarthritis in the UK; an update to the NICE model using data from the CONDOR trial.
Brereton N, Winn B, Akehurst R. Brereton N, et al. Among authors: akehurst r. J Med Econ. 2012;15(3):465-72. doi: 10.3111/13696998.2012.659778. Epub 2012 Feb 14. J Med Econ. 2012. PMID: 22260652
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis.
Tappenden P, Saccardi R, Confavreux C, Sharrack B, Muraro PA, Mancardi GL, Kozak T, Farge-Bancel D, Madan J, Rafia R, Akehurst R, Snowden J. Tappenden P, et al. Among authors: akehurst r. Bone Marrow Transplant. 2010 Jun;45(6):1014-21. doi: 10.1038/bmt.2009.305. Epub 2009 Oct 26. Bone Marrow Transplant. 2010. PMID: 19855441
A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK.
Karnon J, Bakhai A, Brennan A, Pandor A, Flather M, Warren E, Gray D, Akehurst R. Karnon J, et al. Among authors: akehurst r. Int J Cardiol. 2006 May 24;109(3):307-16. doi: 10.1016/j.ijcard.2005.06.026. Epub 2005 Jul 18. Int J Cardiol. 2006. PMID: 16026869
Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United Kingdom.
Karnon J, Tolley K, Oyee J, Jewitt K, Ossa D, Akehurst R. Karnon J, et al. Among authors: akehurst r. Curr Med Res Opin. 2008 Jun;24(6):1609-21. doi: 10.1185/03007990802077442. Epub 2008 Apr 24. Curr Med Res Opin. 2008. PMID: 18439348
97 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback